Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

  • Post published:November 29, 2023
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article Pα+ Psychedelic Patent Analysis (October 2023)

Pα+ Psychedelic Patent Analysis (October 2023)

  • Post published:November 24, 2023
  • Post category:Psychedelic Patent Analysis/Pα+
Read more about the article Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics

Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics

  • Post published:November 20, 2023
  • Post category:Interviews/Pα+
Read more about the article Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research

Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research

  • Post published:November 20, 2023
  • Post category:Interviews/Pα+
Read more about the article Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments

Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments

  • Post published:November 17, 2023
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article Pα+ Library: Psychedelic REMS

Pα+ Library: Psychedelic REMS

  • Post published:November 15, 2023
  • Post category:Library/Pα+
Read more about the article Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

  • Post published:November 10, 2023
  • Post category:Analysis/News/Pα+
Read more about the article Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

  • Post published:November 8, 2023
  • Post category:Analysis/News/Pα+
Read more about the article Psychedelic Bulletin #148 (Pα+)

Psychedelic Bulletin #148 (Pα+)

  • Post published:November 3, 2023
  • Post category:Psychedelic Bulletin/Pα+

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More